# Ilika positions solid state batteries for the future of implantable neurostimulation

- Link: https://www.directorstalkinterviews.com/ilika-positions-solid-state-batteries-for-the-future-of-implantable-neurostimulation/4121252895
- Published: 2026-06-02T14:14:00+01:00
- Author: Amilia Stone

The opioid crisis remains a serious and evolving healthcare challenge. While opioid-
related deaths in the United States have declined modestly, the wider problem has
not been resolved. Prescription opioid misuse has increasingly been overtaken by
the availability of potent illicit synthetic drugs, creating a more complex treatment
environment and raising the risk of overdose and death. The issue is also no longer
confined to North America, with countries including the United Kingdom facing rising
levels of opioid misuse and related harm.

Healthcare providers and policymakers have responded with a broader mix of interventions.
Opioid use disorder is increasingly treated as a chronic medical condition rather
than a criminal issue, supporting more evidence-based and compassionate care. Strategies
such as medication-assisted treatment, wider use of overdose-reversal drugs, tighter
prescribing controls and harm-reduction reforms have improved outcomes. However,
the pace of change in illicit drug supply has left gaps in prevention and treatment.

Neurostimulation is emerging as a complementary approach that may help address some
of these gaps. Unlike drug-based therapies, neurostimulation uses controlled electrical
stimulation to influence nerve activity. Techniques such as vagus nerve stimulation
target specific cranial nerves to help regulate the body’s stress response. By calming
the sympathetic nervous system, these approaches can reduce the physical and psychological
discomfort associated with opioid withdrawal, making detoxification more manageable
for patients.

Small implanted devices are becoming an important part of this field. These devices
deliver controlled electrical pulses and can reduce withdrawal symptoms over a short
period, in some cases within minutes or over several days. By easing the initial
detoxification phase, neurostimulation can help create a bridge to longer-term treatment
options, including medication-assisted therapies. It may also support patients affected
by chronic pain, emotional distress, cravings and co-occurring conditions such as
post-traumatic stress disorder, all of which can complicate recovery.

Implantable neurostimulation systems, often known as implantable pulse generators,
require a stable and long-lasting power source. Traditional non-rechargeable batteries
can be relatively large, limiting where devices can be placed in the body.

By using solid electrolytes rather than liquid or gel-based materials, they can 
support better safety, higher energy density and faster charging. These characteristics
are especially relevant in medical electronics, where reliability, compactness and
patient safety are critical. Their manufacture uses processes similar to those found
in the semiconductor industry, allowing very small and precise devices to be produced
at millimetre scale.

Ilika is developing miniature solid state batteries specifically for implanted medical
applications. Its Stereax technology is designed to support smaller implantable 
devices that can be positioned closer to the target nerve or treatment site. This
miniaturisation may reduce the invasiveness of procedures, increase design flexibility
and improve how therapies are delivered. The compact form of solid state batteries
also allows integration into device manufacturing using established techniques such
as pick-and-place assembly.

Share on:
